Blake Borgeson is Director of RECURSION PHARMACEUTICALS, INC.. Currently has a direct ownership of 7.09 Million shares of RXRX, which is worth approximately $41.2 Million. The most recent transaction as insider was on Feb 06, 2024, when has been sold 11,447 shares (Class A Common Stock) at a price of $9.3 per share, resulting in proceeds of $106,457. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.09M
0.31% 3M change
0.92% 12M change
Total Value Held $41.2 Million

Blake Borgeson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 06 2024
SELL
Open market or private sale
$106,457 $9.3 p/Share
11,447 Reduced 0.16%
7,312,917 Class A Common Stock
Jan 23 2024
SELL
Open market or private sale
$212,171 $10.58 p/Share
20,054 Reduced 0.27%
7,324,364 Class A Common Stock
Jan 09 2024
SELL
Open market or private sale
$270,929 $13.51 p/Share
20,054 Reduced 0.27%
7,344,418 Class A Common Stock
Dec 26 2023
SELL
Open market or private sale
$213,174 $10.63 p/Share
20,054 Reduced 0.27%
7,364,472 Class A Common Stock
Dec 12 2023
SELL
Open market or private sale
$84,707 $7.4 p/Share
11,447 Reduced 0.15%
7,384,526 Class A Common Stock
Nov 28 2023
SELL
Open market or private sale
$76,923 $6.72 p/Share
11,447 Reduced 0.15%
7,395,973 Class A Common Stock
Nov 14 2023
SELL
Open market or private sale
$56,153 $6.32 p/Share
8,885 Reduced 0.12%
7,407,420 Class A Common Stock
Oct 31 2023
SELL
Open market or private sale
$46,823 $5.27 p/Share
8,885 Reduced 0.12%
7,416,305 Class A Common Stock
Oct 17 2023
SELL
Open market or private sale
$58,463 $6.58 p/Share
8,885 Reduced 0.12%
7,425,190 Class A Common Stock
Oct 03 2023
SELL
Open market or private sale
$64,771 $7.29 p/Share
8,885 Reduced 0.12%
7,434,075 Class A Common Stock
Sep 19 2023
SELL
Open market or private sale
$74,278 $8.36 p/Share
8,885 Reduced 0.12%
7,442,960 Class A Common Stock
Sep 05 2023
SELL
Open market or private sale
$78,099 $8.79 p/Share
8,885 Reduced 0.12%
7,451,845 Class A Common Stock
Aug 22 2023
SELL
Open market or private sale
$79,165 $8.91 p/Share
8,885 Reduced 0.12%
7,460,730 Class A Common Stock
Aug 08 2023
SELL
Open market or private sale
$202,400 $11.39 p/Share
17,770 Reduced 0.24%
7,469,615 Class A Common Stock
Jul 25 2023
SELL
Open market or private sale
$273,484 $14.61 p/Share
18,719 Reduced 0.25%
7,487,385 Class A Common Stock
Jul 11 2023
SELL
Open market or private sale
$61,217 $6.89 p/Share
8,885 Reduced 0.12%
7,520,104 Class A Common Stock
Jun 29 2023
SELL
Bona fide gift
-
14,000 Reduced 0.19%
7,506,104 Class A Common Stock
Jun 27 2023
SELL
Open market or private sale
$65,660 $7.39 p/Share
8,885 Reduced 0.12%
7,528,989 Class A Common Stock
Jun 16 2023
BUY
Grant, award, or other acquisition
-
12,612 Added 0.17%
7,537,874 Class A Common Stock
Jun 13 2023
SELL
Open market or private sale
$154,540 $9.98 p/Share
15,485 Reduced 0.21%
7,525,262 Class A Common Stock
May 30 2023
SELL
Open market or private sale
$78,099 $8.79 p/Share
8,885 Reduced 0.12%
7,540,747 Class A Common Stock
May 16 2023
SELL
Open market or private sale
$45,224 $5.09 p/Share
8,885 Reduced 0.12%
7,549,632 Class A Common Stock
Apr 18 2023
SELL
Open market or private sale
$52,688 $5.93 p/Share
8,885 Reduced 0.12%
7,558,517 Class A Common Stock
Apr 04 2023
SELL
Open market or private sale
$58,019 $6.53 p/Share
8,885 Reduced 0.12%
7,567,402 Class A Common Stock
Mar 21 2023
SELL
Open market or private sale
$65,749 $7.4 p/Share
8,885 Reduced 0.12%
7,576,287 Class A Common Stock
BB

Blake Borgeson

Director
Salt Lake City, UT

Track Institutional and Insider Activities on RXRX

Follow RECURSION PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RXRX shares.

Notify only if
Any

Insider Trading

Get notified when an Recursion Pharmaceuticals, Inc. insider buys or sells RXRX shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to RECURSION PHARMACEUTICALS, INC.

Track Activities on RXRX